Its recommendations have come in the context of the current guidelines of the Drugs and Cosmetics Act and Rules, and have been submitted to the Central Drugs Standard Control Organisation (CDSCO).
The recommendations of the committee, which was formed last year by Drug Controller General of India (DGCI), will now be forwarded to the Union Ministry of Health.
The sub-committee, under the chairmanship of Maharashtra Food and Drug Administration (FDA) Commissioner Harshadeep Kamble, has suggested that medicines should be allowed to be sold online in phased manner after establishing sufficient checks and balances.
"Also, there is abuse of medicines through e-pharmacies. People indulge in self-medication,end up taking wrong drugs and there antibiotics misuse. Thus, it can lead to commercial and health exploitation of public at large," said an official of the DGCI.
At present, the online sale of prescriptions drugs (those falling under schedule H, H1, G and X) is illegal. However, for non-prescription drugs, those having the licences can sell them which are without prescription even on online.
Disclaimer: No Business Standard Journalist was involved in creation of this content